HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: clinchem.2008.112458v1 55/3/445    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Bidlingmaier, M. Articles by Bergmann, A. Search for Related Content PubMed PubMed Citation Articles by Bidlingmaier, M. Articles by Bergmann, A.

High-Sensitivity Chemiluminescence Immunoassays for Detection of Growth Hormone Doping in Sports

¹ Medizinische Klinik–Innenstadt, Ludwig-Maximilians-University, Munich, Germany; ² SphingoTec GmbH, Borgsdorf, Germany; ³ Division of Clinical Endocrinology, Department of Medicine, Campus Mitte, Charité-Universitätsmedizin, Berlin, Germany; ⁴ Hospital for Children and Adolescents, University of Leipzig, Germany.

^aAddress correspondence to this author at: Medizinische Klinik Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, D-80336 München, Germany. Fax +49-89-5160-4457; e-mail martin.bidlingmaier{at}med.uni-muenchen.de.

Background: Recombinant human growth hormone (rhGH) is abused in sports, but adequate routine doping tests are lacking. Analysis of serum hGH isoform composition has been shown to be effective in detecting rhGH doping. We developed and validated selective immunoassays for isoform analysis with potential utility for screening and confirmation in doping tests.

Methods: Monoclonal antibodies with preference for pituitary hGH (phGH) or rhGH were used to establish 2 pairs of sandwich-type chemiluminescence assays with differential recognition of rhGH (recA and recB) and phGH (pitA and pitB). We analyzed specimens from volunteers before and after administration of rhGH and calculated ratios between the respective rec- and pit-assay results.

Results: Functional sensitivities were <0.05 µg/L, with intra- and interassay imprecision 8.4% and 13.7%, respectively. In 2 independent cohorts of healthy subjects, rec/pit ratios (median range) were 0.84 (0.09–1.32)/0.81 (0.27–1.21) (recA/pitA) and 0.68 (0.08–1.20)/0.80 (0.25–1.36) (recB/pitB), with no sex difference. In 20 recreational athletes, ratios (median SD) increased after a single injection of rhGH, reaching 350% (73%) (recA/pitA) and 400% (93%) (recB/pitB) of baseline ratios. At a moderate dose (0.033 mg/kg), mean recA/pitA and recB/pitB ratios remained significantly increased for 18 h (men) and 26 h (women). After high-dose rhGH (0.083 mg/kg), mean rec/pit ratios remained increased for 32 h (recA/pitA) and 34 h (recB/pitB) in men and were still increased after 36 h in women.

Conclusions: Using sensitive chemiluminescence assays with preferential recognition of phGH or rhGH, detection of a single injection of rhGH was possible for up to 36 h.

The following articles in journals at HighWire Press have cited this article:

				C. J. Mitchell, A. E. Nelson, M. J. Cowley, W. Kaplan, G. Stone, S. K. Sutton, A. Lau, C. M. Y. Lee, and K. K. Y. Ho Detection of Growth Hormone Doping by Gene Expression Profiling of Peripheral Blood J. Clin. Endocrinol. Metab., December 1, 2009; 94(12): 4703 - 4709. [Abstract] [Full Text] [PDF]

				L. D. Bowers The International Antidoping System and Why It Works Clin. Chem., August 1, 2009; 55(8): 1456 - 1461. [Full Text] [PDF]

				U.-H. Stenman Detection of Illicit Use of Growth Hormone Clin. Chem., March 1, 2009; 55(3): 387 - 388. [Full Text] [PDF]